DeMuth Peter 4
4 · Elicio Therapeutics, Inc. · Filed Dec 10, 2025
Insider Transaction Report
Form 4
DeMuth Peter
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2025-12-09$4.41/sh+362$1,596→ 743 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-12-09−362→ 0 totalExercise: $4.41Exp: 2025-12-10→ Common Stock (362 underlying)
Footnotes (1)
- [F1]The stock option vested and became exercisable as to (i) 25% of the options on the first anniversary of the grant date or December 10, 2016, and (ii) with the remaining shares vesting at a rate of 2.0833% at the end of each month thereafter.